Keyphrases
Automated Speech Analysis
30%
Automatic Speech Recognition
20%
Brain Formation
7%
Clinic Population
61%
Clinical Dementia Rating
10%
Cognition Enhancement
30%
Conceptual Phase
30%
Corticogenesis
7%
Delayed Recall
10%
Dementia Onset
12%
Early Diagnostics
30%
Escapers
7%
Face-to-face Assessment
8%
Headroom
30%
Hippocampal Plasticity
30%
Immediate Recall
10%
Juvenile Form
23%
L-NAME
8%
Language Features
30%
Linguistic Analysis
30%
Linguistic Features
19%
Memory Acquisition
13%
Memory Clinic
30%
Memory Feature
30%
Mild Alzheimer's Disease
30%
Neurocognitive Disorders
42%
Neurodevelopmental Model
7%
Neuropsychiatric Symptoms
30%
Nootropic
30%
Object Location Task
8%
Pediatric Neurodegeneration
7%
Phosphodiesterase Inhibitors
12%
Phosphodiesterase-4 (PDE4)
20%
Psychiatric Conditions
7%
Recessive mutation
7%
Roflumilast
30%
Runcaciguat
30%
Screening Algorithm
12%
Seizure Episode
7%
Semantic Verbal Fluency
20%
Soluble Guanylate Cyclase
21%
Speech Analysis
38%
Speech Features
30%
Subjective Cognitive Decline
10%
Telephone-based
30%
Test Tasks
15%
Two-dimensional Cell Culture
7%
Verbal Learning Task
30%
Verbal Memory
30%
Word Count
10%
Neuroscience
Alzheimer's Disease
6%
Beta-Glucuronidase
10%
Brain Development
7%
Cell Culture
7%
Cell Line
7%
Clinical Dementia Rating
20%
Cognitive Tests
30%
CRISPR
7%
Event-Related Potential
6%
Forskolin
10%
In Vitro
7%
Likert Scale
30%
Luteolin
30%
Mental Disorder
7%
Mild Cognitive Impairment
100%
Neurodegeneration
7%
Neuropsychiatric Symptom
30%
Organoid
30%
Phosphodiesterase
20%
Phosphodiesterase Inhibitor
12%
Phosphodiesterase-4 Inhibitor
10%
Roflumilast
30%
Speech Recognition
30%
Stem Cell
7%
Subjective Cognitive Decline
38%
Synapse
30%
Synapse Formation
15%
Synaptic Transmission
7%
Transcriptome
7%
Verification and Validation
30%
Medicine and Dentistry
Adverse Effect
5%
Alzheimer's Disease
10%
Antiinflammatory Activity
5%
Antiinflammatory Agent
5%
Apoplexy
5%
Biological Marker
30%
Central Nervous System Disease
5%
Clinical Study
5%
Clinical Trial
5%
Cognitive Defect
25%
Disease
5%
Drug Effect
5%
Health Care Cost
12%
Learning Test
6%
Medical Ethics
6%
Mild Cognitive Impairment
41%
Nausea
5%
Nervous System Disorder
5%
Patient Experience
5%
Phosphodiesterase
6%
Phosphodiesterase Inhibitor
12%
Phosphodiesterase IV Inhibitor
30%
Primary Health Care
6%
Primary Outcome
6%
Quality Adjusted Life Year
12%
Quality of Life
5%
Regulatory Affairs
6%
Relative Risk Reduction
6%
Roflumilast
30%
Social Health
5%
Therapeutic Window
5%
Treatment Option
5%
Verbal Learning
6%
Verbal Memory
6%
